1-2 of 2
Rene Swanink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION

Massimo Breccia, MD, Michael J. Mauro, MD, Elias Jabbour, MD, Giuseppe Saglio, MD PhD, Antonio Jiménez-Velasco, MD, Philipp D le Coutre, MD, Irene DeGutis, PharmD, Wasiulla Khan, PhD, Oumar Sy, PhD, Rene Swanink, Jorge E. Cortes, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-137636
Published: 2020
Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Stephen P. Hunger, MD, Vaskar Saha, MD PhD, Meenakshi Devidas, Maria Grazia Valsecchi, Julie Gastier Foster, Gianni Cazzaniga, PhD, Shalini C. Reshmi, PhD, Michael Borowitz, MD PhD, Anthony Moorman, Nyla A. Heerema, PhD, Andrew J. Carroll, III, PhD, Phillip Barnette, M. Monica Monica Gramatges, MD, Kelly Maloney, MD, Weili Sun, MD PhD, Rene Swanink, Amanda Termuhlen, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Lewis B. Silverman, MD, Martin Schrappe, MD PhD, Kirk R. Schultz, William Slayton, MD, Diane Healey, Andrea Biondi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 98.
https://doi.org/10.1182/blood.V130.Suppl_1.98.98
Published: 2017